| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 10/26/2006 | US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity |
| 10/26/2006 | US20060240519 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 10/26/2006 | US20060240517 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060239936 Delivery of anti-migraine compounds through an inhalation route |
| 10/25/2006 | EP1714960A1 Novel therapeutic agent for amyotrophic lateral sclerosis (als) or disease attributable to als |
| 10/25/2006 | EP1714650A1 Arginine-containing compositions for increasing blood flow |
| 10/25/2006 | EP1532152B1 Novel polymorph of n-methyl-n-(3- 3- 2-thienylcarbonyl|-pyrazol- 1,5-alpha|-pyrimidin-7-yl phenyl)acetamide and compositions and methods related thereto |
| 10/25/2006 | EP1458718B1 Quinolinones as prostaglandin receptor ligands |
| 10/25/2006 | CN1852731A Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 10/25/2006 | CN1852719A Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate |
| 10/25/2006 | CN1852718A 2-alkylidene-19-nor-vitamin D derivatives for the treatment of frailty, muscle damage or sarcopenia |
| 10/25/2006 | CN1852716A Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone |
| 10/25/2006 | CN1850176A Tendon relaxation and meridian activation massage oil for infant's brain paralysis |
| 10/25/2006 | CN1850115A Method for preparing bear's gall dropping pills |
| 10/25/2006 | CN1281604C Substituted pyrazole compounds |
| 10/25/2006 | CN1281217C Use of activated carbon in oral medicinal preparation for hyperthyroidism |
| 10/24/2006 | US7125906 Indole derivatives having anti-angiogenetic activity |
| 10/24/2006 | US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 10/24/2006 | US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity |
| 10/24/2006 | US7125875 Cyclic protein tyrosine kinase inhibitors |
| 10/24/2006 | US7125866 Therapeutic applications of pro-apoptotic benzodiazepines |
| 10/19/2006 | US20060235239 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 10/19/2006 | US20060235027 Inhibitors of cdc25 phosphatases |
| 10/19/2006 | US20060234991 Combinations for the treatment of immunoinflammatory disorders |
| 10/19/2006 | US20060234990 Compositions of boswellic acids derived from Boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
| 10/19/2006 | US20060234975 Use of adenosine receptor agonists in therapy |
| 10/19/2006 | US20060233799 Use of il-18 inhibitors for treatment and/or prevention of peripheral vascular diseases |
| 10/19/2006 | US20060233719 Delivery of antidepressants through an inhalation route |
| 10/18/2006 | EP1711175A1 Diurea derivatives |
| 10/18/2006 | CN1847244A Polymorphs of zaleplon and methods for the preparation thereof |
| 10/18/2006 | CN1847229A Novel compounds |
| 10/17/2006 | US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction |
| 10/17/2006 | US7122550 Protein kinase inhibitors |
| 10/17/2006 | US7122208 Administering aliquot of blood which has been treated ex vivo with stressors such as oxidation, thermal stress and electromagnetic radiation; wherein concentration of reactive oxygen species in neuronal cells or tissues is reduced |
| 10/17/2006 | CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 10/17/2006 | CA2260065C Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
| 10/12/2006 | WO2006107902A2 Use of spirostenols to treat mitochondrial disorders |
| 10/12/2006 | WO2006107826A2 Micro-rna's that regulate muscle cells |
| 10/12/2006 | WO2006106727A1 Benzyloxypropylamine derivative |
| 10/12/2006 | WO2006105811A1 Compounds useful as modulators of the proteasome activity |
| 10/12/2006 | US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 10/12/2006 | US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists |
| 10/12/2006 | CA2604133A1 Compounds useful as modulators of the proteasome activity |
| 10/12/2006 | CA2603881A1 Micro-rna's that regulate muscle cells |
| 10/12/2006 | CA2603127A1 Use of spirostenols to treat mitochondrial disorders |
| 10/12/2006 | CA2603030A1 Benzyloxypropylamine derivative |
| 10/11/2006 | EP1710307A2 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 10/11/2006 | EP1709175A2 Hif oligonucleotide decoy molecules |
| 10/11/2006 | EP1363509B1 Compositions containing creatine and creatinine |
| 10/11/2006 | EP0972041B1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
| 10/11/2006 | CN1843343A Methocarbamol dispersion tablet |
| 10/11/2006 | CN1278683C Use of dipeptidyl peptidase IV inhibitor in preparing medicine for treating anxiety neurosis |
| 10/10/2006 | US7119229 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions |
| 10/10/2006 | US7119118 90-95% eicosapentaenoic acid (EPA) and < 5% of docosahexaenoic acid (DHA); treating psychiatric or central nervous disorders |
| 10/10/2006 | US7119117 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 10/10/2006 | US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases |
| 10/10/2006 | US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis |
| 10/10/2006 | US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 10/10/2006 | US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates |
| 10/10/2006 | US7118856 Enzyme catalyst; polypeptides; crystal structure |
| 10/05/2006 | WO2006104280A1 Prophylactic/therapeutic agent for diabetes |
| 10/05/2006 | US20060223881 Use of gamma- tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 10/05/2006 | US20060223800 Pyrazolopyridines and pyrazolopyridazines adn antidiabetics |
| 10/05/2006 | US20060222723 Terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere |
| 10/04/2006 | EP1707566A1 Deazapurines and uses thereof |
| 10/04/2006 | EP1560589B1 Novel complexes of fatty acid esters of polyhydroxyalkanes and niacinamide |
| 10/04/2006 | EP1507527A4 Methods for enhancing motor performance and/or endurance |
| 10/04/2006 | EP1406900B1 Novel compounds, their preparation and use |
| 10/04/2006 | EP1385840B1 Sulfonamides |
| 10/04/2006 | CN1839847A Tizanidine hydrochloride oral disintegrating tablet and preparation method thereof |
| 10/03/2006 | US7115637 Inhibitors of p38 |
| 10/03/2006 | US7115623 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 10/03/2006 | US7115613 Compound of fused nitrogen containing heterocyclic ring, useful for treating prostate and angiogenic disorders |
| 10/03/2006 | US7115554 Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III |
| 10/03/2006 | US7115372 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition |
| 10/03/2006 | US7115250 Heating erectile dysfunction drug to vaporize; cooling to form condensation aerosol; drug delivery |
| 10/03/2006 | CA2288241C Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 09/28/2006 | WO2006100017A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1 ,4- benzoquinone for the treatment of muscular dystrophies |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | US20060217358 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof |
| 09/28/2006 | US20060217349 Having antiinflammatory, anti-pyretic and anti-diarrheal properties |
| 09/28/2006 | US20060216317 Delivery of polynucleotide agents to the central nervous system |
| 09/28/2006 | US20060216244 Delivery of compounds for the treatment of parkinson's through an inhalation route |
| 09/28/2006 | US20060216243 Delivery of Beta-Blockers Through An Inhalation Route |
| 09/28/2006 | US20060216241 Transmucosal absorption through oral mucosa to systemic circulatory system; bioavailability, rapid onset; active ingredient, solvent and low molecular weight hydrocarbon propellant; anxiety, muscle spasms |
| 09/28/2006 | DE102005014080A1 Additionssalze des Tolperison, Verfahren zu deren Herstellung und Verwendung derselben Addition salts of tolperisone, processes for their preparation and use thereof |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1482986B1 Method for determining effect of a clostridial toxin upon a muscle |
| 09/27/2006 | EP1450792B1 Benzazole derivatives for the treatment of scleroderma |
| 09/27/2006 | EP1377580B1 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 09/27/2006 | CN1837195A Pyridine derivatives as nmda-receptor subtype blockers |
| 09/27/2006 | CN1276771C Chinese traditional medicine preparation for treating spasm of eye and facial muscles, and preparing method |
| 09/26/2006 | US7112589 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 09/26/2006 | US7112421 Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto |
| 09/26/2006 | CA2305762C Delayed total release gastrointestinal drug delivery system |
| 09/24/2006 | CA2516364A1 Method of modulation |
| 09/21/2006 | WO2006099480A2 Stress proteins and peptides and methods of use thereof |
| 09/21/2006 | WO2004089282A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/21/2006 | US20060211696 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |